BIOMARKERCENTER

We are one of five Proteome Characterization Centers (PCCs) funded by the National Cancer Institute (NCI). The primary goal of the PCCs is to comprehensively characterize tumors and biospecimens in order to systematically identify, prioritize, and verify cancer-related proteins for the development of biomarkers. The proteomic technologies for cancer proteome characterization include protein microarray, immunoassays, and mass-spectrometry-based methods. The aim is to bridge genomic and proteomic discoveries to medicine using proteomic technologies. Our Center is equipped with a number of proteomic instruments including six mass spectrometers, five liquid chromatography systems, and a protein array platform for proteomic characterizations. In addition, we have two liquid handlers for automated sample processing and protein chemistry and molecular biology platforms for biological and clinical validation of disease-associated proteins... Proteins play essential roles in every cellular..

Primary location: Baltimore United States